AI patents: is there a need to rethink patent law?
Jorge L. Contreras
The patentability of genetic therapies: CAR-T and the medical treatment exclusion around the world (with Luis Gil Abinader)
Rochelle C. Dreyfuss
Trade agreements and their impact on innovation
Transparency in the patent system. Artificial intelligence and the disclosure requirement
Standard Essential Patents. The conflict between open access to standards and the fair reward for innovation
Rethinking the future of the breeder’s exemption, a culture clash?
‘Abuse of rights’ and PAEs in European patent litigation: a case law analysis
Geertrui Van Overwalle
Rethinking IP protection for plants? Comparing plant breeder’s rights, patents and open source
SPC manufacturing waiver – a tool for increasing competitiveness of generic companies or a weapon detrimental for innovators?
Legal instruments stimulating innovation in pharmaceutical industry. Their importance for the Polish pharma
Patent protection of computer implemented inventions. Real life examples
On the meaning of FRAND
Peter R. Slowinski
Artificial intelligence, novelty and inventive step – what role does AI play in patent law today?
Are we still encouraged to protect inventions?
Reconsidering the Bolar exemption: is the legislative framework fit for purpose?
Biosimilars and patent law
Second medical use patents and the boundaries of patent law
Juan Antonio Vives-Vallés
The scope of the Farm-Saved Seed under the UPOV Acts of 1961 and 1978
The importance of being first (with Lisa Herzog)
Patent – a driving force or a costly addition to portfolio? Analysis of non-patent legal factors of marketability in plant biotechnology
Human enhancement and patent law